Proper Name: Influenza Vaccine, Adjuvanted
Manufacturer: Seqirus, Inc.
- Indicated for active immunization of persons 65 years of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.
- April 18, 2019 Approval Letter - FLUAD
- July 13, 2018 Approval Letter - Fluad
- July 7, 2017 Approval Letter - Fluad
- September 9, 2016 Approval Letter Correction - FLUAD
- July 7, 2016 Approval Letter - FLUAD
- November 24, 2015 Approval Letter - FLUAD
- November 23, 2015 Summary Basis for Regulatory Action - FLUAD
- Approval History, Letters, Reviews, and Related Documents - FLUAD
- Supporting Documents older than three years - FLUAD